Fake Meds Online

This book provides a timely criminological investigation into the rapidly growing sale of fake medicines online. Some estimates suggest that the fake medicine trade has now overtaken marijuana and prostitution as the world's largest market for criminal traffickers. This increase has been particularly apparent in the context of various evolutionary phases in information and communications technologies, and the Internet now acts as the main avenue through which this criminal market is expanding. Thus far – despite growing concern and media attention – this extensive, extremely profitable, and ultimately life-threatening online market is yet to be fully explored. Drawing on the authors' own criminological investigation of both the supply and demand sides in the United Kingdom, this study offers the first in-depth and empirically-grounded analysis of the online trade in illicit medicines. Founded on rigorous research, and bolstering a rich area for debate, this book will be of particular interest for scholars of criminology and technology studies.

The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.

"Discusses the economic and financial consequences of pharmaceutical product counterfeiting and describes some of the measures that can be taken to counteract their impact"--Provided by publisher.

We all want to be healthy, live longer and avoid cancer, but too many of us are being scammed by sciencey-sounding crooks and nonsense marketing. Dr Brad McKay, GP and experienced Australian science communicator, has watched how misinformation and 'alternative facts' have come to permeate every facet of our lives, causing many of us to turn away from academic expertise and instead look to social media influencers and dodgy websites to guide our health choices. Fake Medicine looks at the danger of Wellness Warriors, conspiracy theories and vaccine deniers, supplements and fad diets, alternative practitioners and the power of positive thinking, and interrogates the marketing that leads consumers toward dubious products and practices. In the wash of celebrity influencers and miracle cures, this is the essential book to debunk the faux-science and scam marketing of the modern health landscape.

This book overviews and integrates the business and technical issues that pharmaceutical companies need to know in order to combat the major global problem of counterfeit medicines. In addition to discussion of the problems, the author Davison addresses analytical techniques scientists use to detect counterfeits and presents some possible solutions to the threat of counterfeit medical products. Coverage moves from basic overview of the problem, costs / risks to consumers (toxic products, mistrust of drug companies) and business (revenue loss, public trust), government oversight and regulation, authentication strategies (packaging, analytical techniques), product tracking and supply chain, and case studies from around the globe.

This report, one in a series of studies by the OECD and the European Union Intellectual Property Office (EUIPO), enhances understanding of the issues and challenges facing governments, businesses and society posed by the trade in fake pharmaceutical products. Illicit markets for fake pharmaceuticals are attractive for counterfeiters, given the high profit margins, low risks of detection and prosecution, weak penalties, and the ease with which consumers can be deceived into believing that the counterfeit products are genuine. Counterfeit medicines not only cause economic damage for the sector, but are also a significant threat to public health, since fake medicines are often not properly formulated and may contain dangerous ingredients. Fake pharmaceuticals include antibiotics, lifestyle treatments, pain killers, anti-malarial drugs, diabetes treatments and central nervous system medicines.

This is a unique interdisciplinary exploration of the contemporary phenomenon of online medicine purchasing. In this research, Sugiura provides a criminological understanding of the sale of online medicines as well as the traditional illegal markets. Crucially, the practice is investigated from the perspective of web users, moving beyond the headlines and warning campaigns to contextualise the provision of medicines online, to describe this practice and subjective accounts of purchasing medicines from the Web. Drawing together established deviance theories, Respectable Deviance and Purchasing Medicine Online considers the construction of online medicine purchasing, the justifications presented to challenge how it is labelled, and how the behaviour is managed to show how the framing of risks and deviance is challenged online. Offering a much-needed a critical overview of the UK healthcare regulatory system, Sugiura also analyses literature, data and policy documents originating from different countries highlighting that the geographical locations of participants in web forums, online surveys and non-face-to-face interviews cannot always be verified. With broad implications for regulation and safety surrounding medicines online, this innovative and timely study contributes to current online healthcare debates and broadens our understanding of cybercrime. It will be of particular interest to scholars of cybercrime and those interested in the changing nature of deviance.

The Canadian edition of The Little Black Book of Scams is a compact and easy to use reference guide filled with information Canadians can use to protect themselves against a variety of common scams. It debunks common myths about scams, provides contact information for reporting a scam to the correct authority, and offers a step-by-step guide for scam victims to reduce their losses and avoid becoming repeat victims. Consumers and businesses can consult The Little Black Book of Scams to avoid falling victim to social media and mobile phone scams, fake charities and lotteries, dating and romance scams, and many other schemes used to defraud Canadians of their money and personal information.